McAdam LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $271K | Buy |
|
|||||
|
2025
Q1 | $253K | Sell |
|
|||||
|
2024
Q4 | $577K | Sell |
|
|||||
|
2024
Q3 | $756K | Sell |
|
|||||
|
2024
Q2 | $748K | Sell |
|
|||||
|
2024
Q1 | $1.06M | Buy |
|
|||||
|
2023
Q4 | $733K | Buy |
|
|||||
|
2023
Q3 | $578K | Sell |
|
|||||
|
2023
Q2 | $680K | Buy |
|
|||||
|
2023
Q1 | $620K | Sell |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $703K | Sell |
|
|||||
|
2022
Q2 | $679K | Sell |
|
|||||
|
2022
Q1 | $882K | Buy |
|
|||||
|
2021
Q4 | $1.07M | Sell |
|
|||||
|
2021
Q3 | $1.29M | Sell |
|
|||||
|
2021
Q2 | $1.52M | Buy |
|
|||||
|
2021
Q1 | $1.12M | Buy |
|
|||||
|
2020
Q4 | $594K | Buy |
|